Colorectal Liver Metastases. App566536. CA-A0809/47 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2008: Overcoming Collaborative Cancer University of chemo-resistance in Cancer $20,350 30/01/2009 12 Parkville 3010 Australia Melbourne leukaemia: application of Research Vorinostat and ABT-737 to a Scheme new in vivo model of CLL. App566746. CA-A0809/46 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2008: Collaborative Characterisation of the Cancer University of Cancer kConFab BRCAX cohort for $527,107.90 30/01/2009 71 Parkville 3010 Australia Melbourne Research selected breast cancer Scheme susceptibility loci and effect on cancer risk. App566791. CA-A0809/44 Priority Driven Collaborative Cancer Research Scheme Priority Driven (PDCCRS) 2008: A Collaborative randomised trial of Cancer University of Cancer stereotactic vs conventional $286,000 30/01/2009 59 Parkville 3010 Australia Melbourne Research radiotherapy for inoperable Scheme early stage non-small cell lung cancer. App566813. Priority Driven Priority Driven Collaborative Collaborative Cancer Research Scheme Cancer University of Cancer (PDCCRS) 2008: Methylation $294,398.69 30/01/2009 48 Parkville 3010 Australia Melbourne Research in ductal carcinoma in situ. Scheme App566882. CA-A0809/43 Priority Driven Collaborative Priority Driven Cancer Research Scheme Collaborative (PDCCRS) 2008: Cancer University of Cancer Characterisation of a $20,625 30/01/2009 12 Parkville 3010 Australia Melbourne Research associated PIK3CA mutation Scheme using a novel mouse model. App566974. CA-A0809/42 Priority Driven Collaborative Priority Driven Cancer Research Scheme Collaborative (PDCCRS) 2008: Reversing the Cancer University of Cancer debilitating effects of $20,625 30/01/2009 12 Parkville 3010 Australia Melbourne Research radiotherapy-induced Scheme damage in juvenile brain. App566976. CA-A0809/41
Colorectal Liver Metastases. App566536. CA-A0809/47 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46 $20,350 30/01/2009 12 Parkville 3010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44 $527,107.90 30/01/2009 71 Parkville 3010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. $286,000 30/01/2009 59 Parkville 3010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43 $294,398.69 30/01/2009 48 Parkville 3010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42 $20,625 30/01/2009 12 Parkville 3010 Cancer Australia Priority Driven Collaborative Cancer Research Scheme University of Melbourne Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41 $20,625 30/01/2009 12 Parkville 3010 associated